New role for tRNA and its fragment purified from human urinary bladder carcinoma conditioned medium: Inhibition of endothelial cell growth

Journal of Cellular Biochemistry

Volumn 76, Issue 1, 2000, Pages 109-117

  Zhao, Hui ^a   Bojanowski, Krzysztof ^a   Ingber, Donald E ^a   Panigrahy, Dipak ^a   Pepper, Michael S ^b   Montesano, Roberto ^b   Shing, Yuen ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

Endothelial cell inhibitor; Human bladder carcinoma; Transfer RNA

Indexed keywords

TRANSFER RNA;

ARTICLE; BLADDER CARCINOMA; CELL CULTURE; CELL GROWTH; CULTURE MEDIUM; ENDOTHELIUM CELL; GROWTH INHIBITION; GROWTH REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DETERMINATION;

EID: 0033452686     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(20000101)76:1<109::AID-JCB11>3.0.CO;2-K     Document Type: Article

References (36)

1. Borek E, Baliga BS, Gehrke CW, Kuo CW, Belman S, Troll W, Waalkes TP. 1977. High turnover rate of transfer RNA in tumor tissue. Cancer Res 37:3362-3366.
2. Borek E, Kerr SJ. 1972. Atypical transfer RNA's and their origin in neoplastic cells. Adv Cancer Res 15:163-190.
3. Capone JP, Sharp PA, RajBhandary UL. 1985. Amber, ochre and opal suppressor tRNA genes derived from a human serine tRNA gene. EMBO J 4:213-221
4. Crain PF. 1990. Preparation and enzymatic hydrolysis of DNA and RNA for mass spectrometry. Methods Enzymol 193:782-790.
5. Crooke ST. 1992. Therapeutic applications of oligonucleotides. Annu Rev Pharmacol Toxicol 32:329-376.
6. Curcio LD, Bouffard DY, Scanlon KJ. 1997. Oligonucleotides as modulators of cancer gene expression. Pharmacol. Ther. 74:317-332.
7. Davis GE, Gehrke CW, Kuo KC, Agris PF. 1979. Major and modified nucleosides in tRNA hydrolysates by high-performance liquid chromatography. J Chromatogr 173: 281-298.
8. De Luca A, Selvam MP, Sandomenico C, Pepe S, Bianco AR, Ciardiello F, Salomon DS, Normanno N. 1997. Anti-sense oligonucleotides directed against EGF-related growth factors enhance anti-proliferative effect of conventional antitumor drugs in human colon-cancer cells. Int J Cancer 73:277-282.
9. Folkman J. 1995. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med 1:27-31.
10. Folkman J, Haudenschild CC, Zetter BR. 1979. Long-term culture of capillary endothelial cells. Proc Natl Acad Sci USA 76:5217-5221.
11. Gabrilove JL, Welte K, Harris P, Platzer E, Lu L, Levi E, Mertelsmann R, Moore MA. 1986. Pluripoietin alpha: a second human hematopoietic colony-stimulating factor produced by the human bladder carcinoma cell line 5637. Proc Natl Acad Sci USA 83:2478-2482.
12. Gascan H, Anegon I, Praloran V, Naulet J, Godard A, Soulillou JP, Jacques Y. 1990. Constitutive production of human interleukin for DA cells/leukemia inhibitory factor by human tumor cell lines derived from various tissues. J Immunol 144:2592-2598.
13. Gehrke CW, Kuo KC. 1989. Ribonucleoside analysis by reversed-phase high-performance liquid chromatography. J. Chromatography 471:3-36.
14. Gupta RC, Roe BA, Randerath K. 1980. Sequence of human glycine transfer ribonucleic acid (anticodon CCC). Determination by a newly developed thin-layer readout sequencing technique and comparison with othe glycine transfer ribonucleic acids. Biochemistry 19:1699-1705.
15. Hubbell HR, Liu RS, Maxwell BL. 1984. Independent sensitivity of human tumor cell lines to interferon and doubled-stranded RNA. Cancer Res 44:3252-3257.
16. Hubbell HR, Vargas HE, Tsujimoto KL, Gibson GD, Pequignot EC, Bigler RD, Carter WA, Strayer DR. 1992. Antitumor effects of interleukin-2 and mismatched double-stranded RNA, individually and in combination, against a human malignant melanoma xenograft. Cancer Immunology, Immunotherapy 35:151-157.
17. Jellinek D, Green LS, Bell C, Janjic N. 1994. Inhibition of receptor binding by high-affinity RNA ligands to vascular endothelial growth factor. Biochemistry 33:10450-10456.
18. Kanduc D. 1996. Modulation of in vitro kidney cell growth by hepatic transfer RNAs. Biochem Biophys Res Comm 221:735-738.
19. Kornmann M, Arber N, Korc M. 1998. Inhibition of basal and mitogen-stimulated pancreatic cancer cell growth by cyclin D1 antisense is associated with loss of tumorigenicity and potentiation of cytotoxicity to cisplatinum. J Clin Invest 101:344-352.
20. Lane WS, Galat A, Harding MW, Schreiber SL. 1991. Complete amino acid sequence of the FK506 and rapamycin binding protein, FKBP, isolated from calf thymus. J Prot Chem 10:151-160.
21. Larson VM, Clark WR, Hilleman MR. 1969. Influence of synthetic (poly I:C) and viral double-stranded ribonucleic acids on adenovirus 12 oncogenesis in hamsters. Proc Soc Exp Biol Med 131:1002-1011.
22. Lavrovsky Y, Chen S, Roy AK. 1997. Therapeutic potential and mechanism of action of oligonucleotides and ribozymes. Biochem Mol Med 62:11-22.
23. Lemmens R, Vanduffel L, Teuchy H, Culic O. 1996. Regulation of proliferation of LLC-MK2 cells by nucleosides and nucleotides: the role of ecto-enzymes. Biochem J 316:551-557.
24. McEntire JE, Kuo KC, Smith ME, Stalling DL, Richens JW Jr, Zumwalt RW, Gehrke CW, Papermaster BW. 1989. Classification of lung cancer patients and controls by chromatography of modified nucleosides in serum. Cancer Res 49:1057-1062.
25. McNiece IK, Kriegler AB, Quesenberry PJ. 1989. Studies on the myeloid synergistic factor from 5637: comparison with interleukin-1 alpha. Blood 73:919-923.
26. Neidle S. 1997. Recent developments in triple-helix regulation of gene expression. Anti-Cancer Drug Design 12:433-442.
27. O'Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, Flynn E, Birkhead JR, Olsen BR, Folkman J. 1997. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88:277-285.
28. Pepper MS, Ferrara N, Orci L, Montesano R. 1995. Leukemia inhibitory factor (LIF) inhibits angiogenesis in vitro. J Cell Sci 108:73-83.
29. Persidis A. 1997. Ribozyme therapeutics. Nature Biotechnol 15:921-922
30. Rockwell P, O'Connor WJ, King K, Goldstein NI, Zhang LM, Stein CA. 1997. Cell-surface perturbations of the epidermal growth factor and vascular endothelial growth factor receptors by phosphorothioate oligodeoxynucleotides. Proc Natl Acad Sci USA 94:6523-6528.
31. Saxena SK, Rybak SM, Davey RT Jr, Youle RJ, Ackerman EJ. 1992. Angiogenin is a cytotoxic, tRNA-specific ribonuclease in the RNase A superfamily. J Biol Chem 267: 21982-21986.
32. Shing Y, Christofori G, Hanahan D, Ono Y, Sasada R, Igarashi K, Folkman J. 1993. Betacellulin: a mitogen from pancreatic beta cell tumors. Science 259:1604-1607.
33. Speer J, Gehrke CW, Kuo KC, Waalkes TP, Borek E. 1979. tRNA breakdown products as markers for cancer. Cancer 44:2120-2123.
34. Welte K, Platzer E, Lu L, Gabrilove JL, Levi E, Mertelsmann R, Moore MA. 1985. Purification and biochemical characterization of human pluripotent hematopoietic colony-stimulating factor. Proc Natl Acad Sci USA 82: 1526-1530.
35. Yamamoto Y, Tomida M, Hozumi M. 1979. Stimulation of differentiation of mouse myeloid leukemic cells and induction of interferon in the cells by double-stranded polyribonucleotides. Cancer Res 39:4170-4174.
36. Zinzar SN, Svet-Moldavsky GJ, Fogh J, Mann PE, Arlin Z, Iliescu K, Holland JF. 1985. Elaboration of granulocytemacrophage colony-stimulating factor by human tumor cell lines and normal urothelium. Exp Hematol 13:574-580.